Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2017 (2017), Article ID 8737649, 10 pages
https://doi.org/10.1155/2017/8737649
Research Article

Overexpression of Chromosome 21 miRNAs May Affect Mitochondrial Function in the Hearts of Down Syndrome Fetuses

1Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy
2Institute of Experimental Endocrinology and Oncology, National Research Council, 80131 Naples, Italy
3Department of Biosciences and Nutrition, Karolinska Institutet, 17177 Stockholm, Sweden

Correspondence should be addressed to Anna Conti

Received 12 May 2017; Revised 20 July 2017; Accepted 2 August 2017; Published 5 September 2017

Academic Editor: Davide Barbagallo

Copyright © 2017 Antonella Izzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. C. Park, R. A. Mathews, J. R. Zuberbuhler, R. D. Rowe, W. H. Neches, and C. C. Lenox, “Down syndrome with congenital heart malformation,” American Journal of Diseases of Children, vol. 131, no. 1, pp. 29–33, 1977. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Ferencz, C. A. Neill, J. A. Boughman, J. D. Rubin, J. I. Brenner, and L. W. Perry, “Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study,” The Journal of Pediatrics, vol. 114, no. 1, pp. 79–86, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. J. R. Korenberg, X. N. Chen, R. Schipper et al., “Down syndrome phenotypes: the consequences of chromosomal imbalance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 11, pp. 4997–5001, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. G. M. Barlow, X. N. Chen, Z. Y. Shi et al., “Down syndrome congenital heart disease: a narrowed region and a candidate gene,” Genetics in Medicine, vol. 3, no. 2, pp. 91–101, 2001. View at Publisher · View at Google Scholar
  5. C. Liu, P. V. Belichenko, L. Zhang et al., “Mouse models for Down syndrome-associated developmental cognitive disabilities,” Developmental Neuroscience, vol. 33, no. 5, pp. 404–413, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Liu, M. Morishima, X. Jiang et al., “Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice,” Human Genetics, vol. 133, no. 6, pp. 743–753, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Conti, F. Fabbrini, P. D'Agostino et al., “Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy,” BMC Genomics, vol. 8, p. 268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Ambros and X. Chen, “The regulation of genes and genomes by small RNAs,” Development, vol. 134, no. 9, pp. 1635–1641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Zhao, J. F. Ransom, A. Li et al., “Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2,” Cell, vol. 129, no. 2, pp. 303–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Yang, H. Lin, J. Xiao et al., “The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2,” Nature Medicine, vol. 13, no. 4, pp. 486–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Care, D. Catalucci, F. Felicetti et al., “MicroRNA-133 controls cardiac hypertrophy,” Nature Medicine, vol. 13, no. 5, pp. 613–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. E. van Rooij and E. N. Olson, “microRNAs put their signatures on the heart,” Physiological Genomics, vol. 31, no. 3, pp. 365-366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Letourneau and S. E. Antonarakis, “Genomic determinants in the phenotypic variability of Down syndrome,” Progress in Brain Research, vol. 197, pp. 15–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. S. Elton, S. E. Sansom, and M. M. Martin, “Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins,” RNA Biology, vol. 7, no. 5, pp. 540–547, 2010. View at Publisher · View at Google Scholar
  15. P. Sethupathy, C. Borel, M. Gagnebin et al., “Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes,” American Journal of Human Genetics, vol. 81, no. 2, pp. 405–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. O'Connell, D. S. Rao, A. A. Chaudhuri et al., “Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder,” The Journal of Experimental Medicine, vol. 205, no. 3, pp. 585–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Ozen, C. J. Creighton, M. Ozdemir, and M. Ittmann, “Widespread deregulation of microRNA expression in human prostate cancer,” Oncogene, vol. 27, no. 12, pp. 1788–1793, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Coppola, A. Romito, C. Borel et al., “Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications,” Stem Cell Research, vol. 12, no. 2, pp. 323–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Wu, Z. Gong, L. Sun, L. Ma, and Q. Wang, “MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4,” Cell Proliferation, vol. 50, no. 3, 2017. View at Publisher · View at Google Scholar
  20. S. Malinge, S. Izraeli, and J. D. Crispino, “Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome,” Blood, vol. 113, no. 12, pp. 2619–2628, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Piccoli, A. Izzo, R. Scrima et al., “Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects,” Human Molecular Genetics, vol. 22, no. 6, pp. 1218–1232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Izzo, R. Manco, F. Bonfiglio et al., “NRIP1/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome,” Human Molecular Genetics, vol. 23, no. 16, pp. 4406–4419, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Schindelin, I. Arganda-Carreras, E. Frise et al., “Fiji: an open-source platform for biological-image analysis,” Nature Methods, vol. 9, no. 7, pp. 676–682, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Reczko, M. Maragkakis, P. Alexiou, I. Grosse, and A. G. Hatzigeorgiou, “Functional microRNA targets in protein coding sequences,” Bioinformatics, vol. 28, no. 6, pp. 771–776, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. W. Nam, O. S. Rissland, D. Koppstein et al., “Global analyses of the effect of different cellular contexts on microRNA targeting,” Molecular Cell, vol. 53, no. 6, pp. 1031–1043, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kertesz, N. Iovino, U. Unnerstall, U. Gaul, and E. Segal, “The role of site accessibility in microRNA target recognition,” Nature Genetics, vol. 39, no. 10, pp. 1278–1284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Bandyopadhyay and R. Mitra, “TargetMiner: microRNA target prediction with systematic identification of tissue-specific negative examples,” Bioinformatics, vol. 25, no. 20, pp. 2625–2631, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Wong and X. Wang, “miRDB: an online resource for microRNA target prediction and functional annotations,” Nucleic Acids Research, vol. 43, Database issue, pp. D146–D152, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. K. C. Miranda, T. Huynh, Y. Tay et al., “A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes,” Cell, vol. 126, no. 6, pp. 1203–1217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Krek, D. Grun, M. N. Poy et al., “Combinatorial microRNA target predictions,” Nature Genetics, vol. 37, no. 5, pp. 495–500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Betel, A. Koppal, P. Agius, C. Sander, and C. Leslie, “Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites,” Genome Biology, vol. 11, no. 8, article R90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Durinck, P. T. Spellman, E. Birney, and W. Huber, “Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt,” Nature Protocols, vol. 4, no. 8, pp. 1184–1191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Wang, D. Duncan, Z. Shi, and B. Zhang, “WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013,” Nucleic Acids Research, vol. 41, Web Server issue, pp. W77–W83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Brennecke, A. Stark, R. B. Russell, and S. M. Cohen, “Principles of microRNA-target recognition,” PLoS Biology, vol. 3, article e85, p. 3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Helwak, G. Kudla, T. Dudnakova, and D. Tollervey, “Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding,” Cell, vol. 153, no. 3, pp. 654–665, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. S. W. Chi, J. B. Zang, A. Mele, and R. B. Darnell, “Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps,” Nature, vol. 460, no. 7254, pp. 479–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. C. H. Chou, N. W. Chang, S. Shrestha et al., “miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database,” Nucleic Acids Research, vol. 44, no. D1, pp. D239–D247, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Rennie, S. Kanoria, C. Liu et al., “STarMirDB: a database of microRNA binding sites,” RNA Biology, vol. 13, no. 6, pp. 554–560, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. D. P. Bartel, “MicroRNAs: target recognition and regulatory functions,” Cell, vol. 136, no. 2, pp. 215–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Tokumaru, M. Suzuki, H. Yamada, M. Nagino, and T. Takahashi, “let-7 regulates Dicer expression and constitutes a negative feedback loop,” Carcinogenesis, vol. 29, no. 11, pp. 2073–2077, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Palmieri, S. Alberio, I. Pisano et al., “Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy,” Human Molecular Genetics, vol. 14, no. 20, pp. 3079–3088, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Li, C. K. Warner, J. A. Hodge et al., “A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed,” The Journal of Biological Chemistry, vol. 264, no. 24, pp. 13998–14004, 1989. View at Google Scholar
  43. S. Arbuzova, T. Hutchin, and H. Cuckle, “Mitochondrial dysfunction and Down’s syndrome,” BioEssays, vol. 24, no. 8, pp. 681–684, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Subramaniam, P. Golik, D. G. Murdock et al., “MITOCHIP assessment of differential gene expression in the skeletal muscle of Ant1 knockout mice: coordinate regulation of OXPHOS, antioxidant, and apoptotic genes,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1777, no. 7-8, pp. 666–675, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Bofill-De Ros, M. Santos, M. Vila-Casadesus et al., “Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA sponges,” BMC Genomics, vol. 16, p. 907, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Quinones-Lombrana and J. G. Blanco, “Chromosome 21-derived hsa-miR-155-5p regulates mitochondrial biogenesis by targeting mitochondrial transcription factor A (TFAM),” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1852, no. 7, pp. 1420–1427, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Y. Seok, J. Chen, M. Kataoka et al., “Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy,” Circulation Research, vol. 114, no. 10, pp. 1585–1595, 2014. View at Publisher · View at Google Scholar · View at Scopus